Skip to content
healthcare.dev

DEXTROAMPHETAMINE SULFATE

NDC 11534-189, dextroamphetamine sulfate, tablet, from SUNRISE PHARMACEUTICAL, INC..

Product NDC
11534-189
Status
Listed
Labeler
SUNRISE PHARMACEUTICAL, INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210059
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11534-189 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXTROAMPHETAMINE SULFATE10 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
11534-189-0111534018901100 TABLET in 1 BOTTLE (11534-189-01)
11534-189-03115340189031000 TABLET in 1 BOTTLE (11534-189-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/93b3a40f-b7ac-4047-8ff5-3e34c2d75193
  • NADAC price for package 11534018901

    GET /v1/drugs/nadac/11534018901

Use it

Look up 11534-189 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11534-189 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11534-189. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.